The Intersection of mRNA Biology and Artificial Intelligence is Yielding Unique mRNA Drug Candidates

Anima Biotech's Yochi Slonim explains how Anima's unique technology can accelerate the discovery and development of small molecule drugs targeting mRNA translation, transport, and relocalization.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: